The Readout Loud
Podcast tekijän mukaan STAT - Torstaisin
350 Jaksot
-
326: Crypto for CRISPR, a new RNAi startup, & a Nobel for AI
Julkaistiin: 10.10.2024 -
325: Biden's health care AI czar, a new obesity company, and its dealmaking CEO
Julkaistiin: 3.10.2024 -
From Tradeoffs: Race to the Bottom
Julkaistiin: 28.9.2024 -
324: Genentech's cancer pivot, Pfizer's sickle cell withdrawal, and a new schizophrenia drug
Julkaistiin: 26.9.2024 -
323: Cannabinoids for weight loss, a cancelled ad comm, and the Fed lowers interest rates
Julkaistiin: 19.9.2024 -
322: A new threat to Merck's blockbuster cancer treatment, Moderna's cutbacks, and obesity drugs for kids
Julkaistiin: 12.9.2024 -
321: Summit's upcoming cancer results, Recursion's mixed data, and the next big obesity target
Julkaistiin: 5.9.2024 -
320: Jim Wilson's next venture, a surprise startup shutdown, & Lilly's Zepbound strategy
Julkaistiin: 29.8.2024 -
From "Say More": What Happens When AI Decides Your Medical Coverage
Julkaistiin: 23.8.2024 -
319: BioMarin's executive shakeup, a GLP-1 lowers diabetes risk, and a deep look at Recursion's AI bona fides
Julkaistiin: 22.8.2024 -
318: Drug pricing drops & psychedelics under fire
Julkaistiin: 15.8.2024 -
317: VC struggles, drug pricing negotiations, & Novo's abrupt Wegovy decision
Julkaistiin: 8.8.2024 -
316: The long journey to make malaria vaccines, and Sarepta's ties with patient advocates
Julkaistiin: 1.8.2024 -
315: UnitedHealth's doctor empire, an FDA departure, and Viking's obesity moves
Julkaistiin: 25.7.2024 -
314: JD Vance's biotech ties, Cassava resignations, and insulin shortages
Julkaistiin: 18.7.2024 -
313: Biotech layoffs, founder-focused VC, & a big pharma exit
Julkaistiin: 11.7.2024 -
312: Medicare coverage for GLP-1 drugs, AI, and health care at the presidential debate
Julkaistiin: 27.6.2024 -
311: Fauci's memoir, Alnylam's tenuous trial, and a mid-year review
Julkaistiin: 20.6.2024 -
310: Duchenne gene therapy setback, Alzheimer's drug endorsement & why a STAT reporter buys weed (for journalism)
Julkaistiin: 13.6.2024 -
309: Psychedelics at the FDA, ASCO recap, & MorphoSys update
Julkaistiin: 6.6.2024
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
